Europe Apheresis Market Size, Share & Industry Trends Analysis Report By Procedure (Donor/Automated and Therapeutic), By Product, By Method, By End User, By Component, By Country and Growth Forecast, 2022 - 2028

The Europe Apheresis Market would witness market growth of 7.6% CAGR during the forecast period (2022-2028).

Disease such as Sickle cell is a genetic disease where the red blood cells are abnormally shaped like sickles and cannot effectively transfer oxygen around the body. If they create a sickle cell emergency, their sickled red blood cells can be scrapped and substituted with healthy cells from a blood donor via erythrocytapheresis.

Patients with leukemia may have an abnormally high number of white blood cells, causing the blood to clump and intrude on organ function. The leukapheresis procedure removes abnormal white blood cells while returning the rest of the blood to the patient whereas Myasthenia gravis is a condition in which unusual antibodies (proteins) in the blood interfere with nerve-muscle communication. Thrombotic thrombocytopenic purpura (TTP) is a rare blood disorder that causes platelet clusters to establish all through the skin caused to a lack of a necessary blood enzyme.

The United Kingdom has one of the safest blood suppliers in the entire globe, and decisions about safety efforts are based on risk evidence, ethical considerations, and operational sustainability, as well as cost. When the evidence and/or the danger are unknown, SaBTO recommends precautionary advice. The SaBTO (Advisory Committee on the Safety of Blood, Tissues, and Organs) is an independent committee sponsored by the Ministry of Health and Social Care; members are chosen through an interview process following a public announcement. Representatives advise the four UK health ministers on the safety of blood, cells, tissues, and organs. Policies are available on the company's website and are updated regularly.

Advisory Committee on the Safety of Blood, Tissues and Organs reviews its recommendations on a regular basis, as well as when new information comes to light. The United Kingdom also has one of the world's premier haemovigilance organizations, which is in charge of collecting reports of transfusion-related adverse events so that the effect of policy decisions may be tracked.

The Germany market dominated the Europe Apheresis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $260.1 million by 2028. The UK market is poised to grow at a CAGR of 6.7% during (2022 - 2028). Additionally, The France market would display a CAGR of 8.4% during (2022 - 2028).

Based on Procedure, the market is segmented into Donor/Automated and Therapeutic. Based on Product, the market is segmented into Disposable & Reagents, Devices, and Software. Based on Method, the market is segmented into Centrifugation, Membrane Separation, and Selective Adsorption. Based on End User, the market is segmented into Blood Centers, Hospitals, and Others. Based on Component, the market is segmented into Plasma (Plasmapheresis), Platelets (Plateletpheresis), Leukocytes (Leukapheresis or leukopheresis), Lymphocytes (Lymphopheresis or lymphapheresis), and RBC's (Erythropheresis). Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Apheresis Market will Hit $4 Billion by 2028, at a CAGR of 8.1%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Asahi Kasei Medical Co., Ltd., Kaneka Corporation, Cerus Corporation, B. Braun Melsungen AG, Nikkiso Co., Ltd., Charles River Laboratories International, Inc., and SB Kawasumi Laboratories, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Procedure

• Donor/Automated
• Therapeutic

By Product

• Disposable & Reagents
• Devices
• Software

By Method

• Centrifugation
• Membrane Separation
• Selective Adsorption

By End User

• Blood Centers
• Hospitals
• Others

By Component

• Plasma (Plasmapheresis)
• Platelets (Plateletpheresis)
• Leukocytes (Leukapheresis or leukopheresis)
• Lymphocytes (Lymphopheresis or lymphapheresis)
• RBC's (Erythropheresis)

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Haemonetics Corporation
• Fresenius SE & Co. KGaA
• Terumo Corporation
• Asahi Kasei Medical Co., Ltd
• Kaneka Corporation
• Cerus Corporation
• B.Braun Melsungen AG
• Nikkiso Co., Ltd
• Charles River Laboratories International, Inc.
• SB Kawasumi Laboratories, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Apheresis Market, by Procedure
1.4.2 Europe Apheresis Market, by Product
1.4.3 Europe Apheresis Market, by Method
1.4.4 Europe Apheresis Market, by End User
1.4.5 Europe Apheresis Market, by Component
1.4.6 Europe Apheresis Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Geographical Expansions
3.2.4 Approval and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Europe Apheresis Market by Procedure
4.1 Europe Donor/Automated Market by Country
4.2 Europe Therapeutic Market by Country

Chapter 5. Europe Apheresis Market by Product
5.1 Europe Disposable & Reagents Market by Country
5.2 Europe Devices Market by Country
5.3 Europe Software Market by Country

Chapter 6. Europe Apheresis Market by Method
6.1 Europe Centrifugation Market by Country
6.2 Europe Membrane Separation Market by Country
6.3 Europe Selective Adsorption Market by Country

Chapter 7. Europe Apheresis Market by End User
7.1 Europe Blood Centers Market by Country
7.2 Europe Hospitals Market by Country
7.3 Europe Others Market by Country

Chapter 8. Europe Apheresis Market by Component
8.1 Europe Plasma (Plasmapheresis) Market by Country
8.2 Europe Platelets (Plateletpheresis) Market by Country
8.3 Europe Leukocytes (Leukapheresis or leukopheresis) Market by Country
8.4 Europe Lymphocytes (Lymphopheresis or lymphapheresis) Market by Country
8.5 Europe RBC's (Erythropheresis) Market by Country

Chapter 9. Europe Apheresis Market by Country
9.1 Germany Apheresis Market
9.1.1 Germany Apheresis Market by Procedure
9.1.2 Germany Apheresis Market by Product
9.1.3 Germany Apheresis Market by Method
9.1.4 Germany Apheresis Market by End User
9.1.5 Germany Apheresis Market by Component
9.2 UK Apheresis Market
9.2.1 UK Apheresis Market by Procedure
9.2.2 UK Apheresis Market by Product
9.2.3 UK Apheresis Market by Method
9.2.4 UK Apheresis Market by End User
9.2.5 UK Apheresis Market by Component
9.3 France Apheresis Market
9.3.1 France Apheresis Market by Procedure
9.3.2 France Apheresis Market by Product
9.3.3 France Apheresis Market by Method
9.3.4 France Apheresis Market by End User
9.3.5 France Apheresis Market by Component
9.4 Russia Apheresis Market
9.4.1 Russia Apheresis Market by Procedure
9.4.2 Russia Apheresis Market by Product
9.4.3 Russia Apheresis Market by Method
9.4.4 Russia Apheresis Market by End User
9.4.5 Russia Apheresis Market by Component
9.5 Spain Apheresis Market
9.5.1 Spain Apheresis Market by Procedure
9.5.2 Spain Apheresis Market by Product
9.5.3 Spain Apheresis Market by Method
9.5.4 Spain Apheresis Market by End User
9.5.5 Spain Apheresis Market by Component
9.6 Italy Apheresis Market
9.6.1 Italy Apheresis Market by Procedure
9.6.2 Italy Apheresis Market by Product
9.6.3 Italy Apheresis Market by Method
9.6.4 Italy Apheresis Market by End User
9.6.5 Italy Apheresis Market by Component
9.7 Rest of Europe Apheresis Market
9.7.1 Rest of Europe Apheresis Market by Procedure
9.7.2 Rest of Europe Apheresis Market by Product
9.7.3 Rest of Europe Apheresis Market by Method
9.7.4 Rest of Europe Apheresis Market by End User
9.7.5 Rest of Europe Apheresis Market by Component

Chapter 10. Company Profiles
10.1 Fresenius SE & Co. KGaA
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Acquisition and Mergers:
10.1.5.2 Geographical Expansions:
10.2 Terumo Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Partnerships, Collaborations, and Agreements:
10.2.4.2 Geographical Expansions:
10.2.4.3 Approvals and Trials:
10.3 Charles River Laboratories International, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Recent strategies and developments:
10.3.4.1 Acquisition and Mergers:
10.4 Haemonetics Corporation
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Approvals and Trials:
10.5 Asahi Kasei Medical Co., Ltd.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Acquisition and Mergers:
10.6 Kaneka Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.7 Cerus Corporation
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expense
10.8 B. Braun Melsungen AG
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expenses
10.9 Nikkiso Co., Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental Analysis
10.9.4 Research & Development Expense
10.10. SB Kawasumi Laboratories, Inc.
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis

TABLE 1 Europe Apheresis Market, 2018 - 2021, USD Million
TABLE 2 Europe Apheresis Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Apheresis Market
TABLE 4 Acquisition and Mergers– Apheresis Market
TABLE 5 Geographical expansions - Apheresis Market
TABLE 6 Approvals and tials- Apheresis Market
TABLE 7 Europe Apheresis Market by Procedure, 2018 - 2021, USD Million
TABLE 8 Europe Apheresis Market by Procedure, 2022 - 2028, USD Million
TABLE 9 Europe Donor/Automated Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Donor/Automated Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Apheresis Market by Product, 2018 - 2021, USD Million
TABLE 14 Europe Apheresis Market by Product, 2022 - 2028, USD Million
TABLE 15 Europe Disposable & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Disposable & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Devices Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Devices Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Software Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Software Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Apheresis Market by Method, 2018 - 2021, USD Million
TABLE 22 Europe Apheresis Market by Method, 2022 - 2028, USD Million
TABLE 23 Europe Centrifugation Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Centrifugation Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Membrane Separation Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Membrane Separation Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Selective Adsorption Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Selective Adsorption Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe Apheresis Market by End User, 2018 - 2021, USD Million
TABLE 30 Europe Apheresis Market by End User, 2022 - 2028, USD Million
TABLE 31 Europe Blood Centers Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Blood Centers Market by Country, 2022 - 2028, USD Million
TABLE 33 Europe Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 34 Europe Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 35 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 36 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 37 Europe Apheresis Market by Component, 2018 - 2021, USD Million
TABLE 38 Europe Apheresis Market by Component, 2022 - 2028, USD Million
TABLE 39 Europe Plasma (Plasmapheresis) Market by Country, 2018 - 2021, USD Million
TABLE 40 Europe Plasma (Plasmapheresis) Market by Country, 2022 - 2028, USD Million
TABLE 41 Europe Platelets (Plateletpheresis) Market by Country, 2018 - 2021, USD Million
TABLE 42 Europe Platelets (Plateletpheresis) Market by Country, 2022 - 2028, USD Million
TABLE 43 Europe Leukocytes (Leukapheresis or leukopheresis) Market by Country, 2018 - 2021, USD Million
TABLE 44 Europe Leukocytes (Leukapheresis or leukopheresis) Market by Country, 2022 - 2028, USD Million
TABLE 45 Europe Lymphocytes (Lymphopheresis or lymphapheresis) Market by Country, 2018 - 2021, USD Million
TABLE 46 Europe Lymphocytes (Lymphopheresis or lymphapheresis) Market by Country, 2022 - 2028, USD Million
TABLE 47 Europe RBC's (Erythropheresis) Market by Country, 2018 - 2021, USD Million
TABLE 48 Europe RBC's (Erythropheresis) Market by Country, 2022 - 2028, USD Million
TABLE 49 Europe Apheresis Market by Country, 2018 - 2021, USD Million
TABLE 50 Europe Apheresis Market by Country, 2022 - 2028, USD Million
TABLE 51 Germany Apheresis Market, 2018 - 2021, USD Million
TABLE 52 Germany Apheresis Market, 2022 - 2028, USD Million
TABLE 53 Germany Apheresis Market by Procedure, 2018 - 2021, USD Million
TABLE 54 Germany Apheresis Market by Procedure, 2022 - 2028, USD Million
TABLE 55 Germany Apheresis Market by Product, 2018 - 2021, USD Million
TABLE 56 Germany Apheresis Market by Product, 2022 - 2028, USD Million
TABLE 57 Germany Apheresis Market by Method, 2018 - 2021, USD Million
TABLE 58 Germany Apheresis Market by Method, 2022 - 2028, USD Million
TABLE 59 Germany Apheresis Market by End User, 2018 - 2021, USD Million
TABLE 60 Germany Apheresis Market by End User, 2022 - 2028, USD Million
TABLE 61 Germany Apheresis Market by Component, 2018 - 2021, USD Million
TABLE 62 Germany Apheresis Market by Component, 2022 - 2028, USD Million
TABLE 63 UK Apheresis Market, 2018 - 2021, USD Million
TABLE 64 UK Apheresis Market, 2022 - 2028, USD Million
TABLE 65 UK Apheresis Market by Procedure, 2018 - 2021, USD Million
TABLE 66 UK Apheresis Market by Procedure, 2022 - 2028, USD Million
TABLE 67 UK Apheresis Market by Product, 2018 - 2021, USD Million
TABLE 68 UK Apheresis Market by Product, 2022 - 2028, USD Million
TABLE 69 UK Apheresis Market by Method, 2018 - 2021, USD Million
TABLE 70 UK Apheresis Market by Method, 2022 - 2028, USD Million
TABLE 71 UK Apheresis Market by End User, 2018 - 2021, USD Million
TABLE 72 UK Apheresis Market by End User, 2022 - 2028, USD Million
TABLE 73 UK Apheresis Market by Component, 2018 - 2021, USD Million
TABLE 74 UK Apheresis Market by Component, 2022 - 2028, USD Million
TABLE 75 France Apheresis Market, 2018 - 2021, USD Million
TABLE 76 France Apheresis Market, 2022 - 2028, USD Million
TABLE 77 France Apheresis Market by Procedure, 2018 - 2021, USD Million
TABLE 78 France Apheresis Market by Procedure, 2022 - 2028, USD Million
TABLE 79 France Apheresis Market by Product, 2018 - 2021, USD Million
TABLE 80 France Apheresis Market by Product, 2022 - 2028, USD Million
TABLE 81 France Apheresis Market by Method, 2018 - 2021, USD Million
TABLE 82 France Apheresis Market by Method, 2022 - 2028, USD Million
TABLE 83 France Apheresis Market by End User, 2018 - 2021, USD Million
TABLE 84 France Apheresis Market by End User, 2022 - 2028, USD Million
TABLE 85 France Apheresis Market by Component, 2018 - 2021, USD Million
TABLE 86 France Apheresis Market by Component, 2022 - 2028, USD Million
TABLE 87 Russia Apheresis Market, 2018 - 2021, USD Million
TABLE 88 Russia Apheresis Market, 2022 - 2028, USD Million
TABLE 89 Russia Apheresis Market by Procedure, 2018 - 2021, USD Million
TABLE 90 Russia Apheresis Market by Procedure, 2022 - 2028, USD Million
TABLE 91 Russia Apheresis Market by Product, 2018 - 2021, USD Million
TABLE 92 Russia Apheresis Market by Product, 2022 - 2028, USD Million
TABLE 93 Russia Apheresis Market by Method, 2018 - 2021, USD Million
TABLE 94 Russia Apheresis Market by Method, 2022 - 2028, USD Million
TABLE 95 Russia Apheresis Market by End User, 2018 - 2021, USD Million
TABLE 96 Russia Apheresis Market by End User, 2022 - 2028, USD Million
TABLE 97 Russia Apheresis Market by Component, 2018 - 2021, USD Million
TABLE 98 Russia Apheresis Market by Component, 2022 - 2028, USD Million
TABLE 99 Spain Apheresis Market, 2018 - 2021, USD Million
TABLE 100 Spain Apheresis Market, 2022 - 2028, USD Million
TABLE 101 Spain Apheresis Market by Procedure, 2018 - 2021, USD Million
TABLE 102 Spain Apheresis Market by Procedure, 2022 - 2028, USD Million
TABLE 103 Spain Apheresis Market by Product, 2018 - 2021, USD Million
TABLE 104 Spain Apheresis Market by Product, 2022 - 2028, USD Million
TABLE 105 Spain Apheresis Market by Method, 2018 - 2021, USD Million
TABLE 106 Spain Apheresis Market by Method, 2022 - 2028, USD Million
TABLE 107 Spain Apheresis Market by End User, 2018 - 2021, USD Million
TABLE 108 Spain Apheresis Market by End User, 2022 - 2028, USD Million
TABLE 109 Spain Apheresis Market by Component, 2018 - 2021, USD Million
TABLE 110 Spain Apheresis Market by Component, 2022 - 2028, USD Million
TABLE 111 Italy Apheresis Market, 2018 - 2021, USD Million
TABLE 112 Italy Apheresis Market, 2022 - 2028, USD Million
TABLE 113 Italy Apheresis Market by Procedure, 2018 - 2021, USD Million
TABLE 114 Italy Apheresis Market by Procedure, 2022 - 2028, USD Million
TABLE 115 Italy Apheresis Market by Product, 2018 - 2021, USD Million
TABLE 116 Italy Apheresis Market by Product, 2022 - 2028, USD Million
TABLE 117 Italy Apheresis Market by Method, 2018 - 2021, USD Million
TABLE 118 Italy Apheresis Market by Method, 2022 - 2028, USD Million
TABLE 119 Italy Apheresis Market by End User, 2018 - 2021, USD Million
TABLE 120 Italy Apheresis Market by End User, 2022 - 2028, USD Million
TABLE 121 Italy Apheresis Market by Component, 2018 - 2021, USD Million
TABLE 122 Italy Apheresis Market by Component, 2022 - 2028, USD Million
TABLE 123 Rest of Europe Apheresis Market, 2018 - 2021, USD Million
TABLE 124 Rest of Europe Apheresis Market, 2022 - 2028, USD Million
TABLE 125 Rest of Europe Apheresis Market by Procedure, 2018 - 2021, USD Million
TABLE 126 Rest of Europe Apheresis Market by Procedure, 2022 - 2028, USD Million
TABLE 127 Rest of Europe Apheresis Market by Product, 2018 - 2021, USD Million
TABLE 128 Rest of Europe Apheresis Market by Product, 2022 - 2028, USD Million
TABLE 129 Rest of Europe Apheresis Market by Method, 2018 - 2021, USD Million
TABLE 130 Rest of Europe Apheresis Market by Method, 2022 - 2028, USD Million
TABLE 131 Rest of Europe Apheresis Market by End User, 2018 - 2021, USD Million
TABLE 132 Rest of Europe Apheresis Market by End User, 2022 - 2028, USD Million
TABLE 133 Rest of Europe Apheresis Market by Component, 2018 - 2021, USD Million
TABLE 134 Rest of Europe Apheresis Market by Component, 2022 - 2028, USD Million
TABLE 135 key information – Fresenius SE & Co. KGaA
TABLE 136 Key Information – Terumo Corporation
TABLE 137 key information – Charles River Laboratories International, Inc.
TABLE 138 key information – Haemonetics Corporation
TABLE 139 Key Information – Asahi Kasei Medical Co., Ltd.
TABLE 140 Key Information – Kaneka Corporation
TABLE 141 key information – Cerus Corporation
TABLE 142 key Information – B. Braun Melsungen AG
TABLE 143 Key Information – Nikkiso Co., Ltd.
TABLE 144 Key Information – SB Kawasumi Laboratories, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent strategies and developments: Fresenius SE & Co. KGaA
FIG 5 Recent strategies and developments: Terumo Corporation